The Life Sciences Greenhouses are models of effectiveness and efficiency. They capture the innovation potential of the life sciences industry and nurture that potential with critical early-stage funding and sector-specific business expertise. Pennsylvanians benefit directly as new companies are formed, jobs are created, additional capital is attracted to the Commonwealth, and life-saving technologies reach patients.
The table below highlights just a few of the breakthrough products brought to market by companies backed by the PA Life Sciences Greenhouse Initiative.
| Company | Product Name | Use | Regulatory Approval |
| Avid/Lilly | Amyvid™ (florbetapir F18) | Determine presence of beta amyloid plaque in patients with cognitive impairment | FDA |
| InfraScan | InfraScanner 2000 | Hand held device to detect brain hematoma after head trauma | FDA |
| Sans Rosa/Galderma | Mirvaso® (bromidine gel) | Treatment of skin redness known as rosacea | FDA |
| Ceptaris/Helsinn | VALCHLOR™ (mechlorethamine) gel | topical treatment of stage 1A and @@B mycosis fundoides-type cutaneous T-cell lymphoma (CTCL) | FDA |
| Indigo BioSciences | Nuclear receptor assay kits and services | Drug screening | Not Applicable |
| Maculogix | AdaptDx™ | Macular Degeneration | FDA |
| Micro Interventional Devices | Permaseal™ | Heart Valve Repair | FDA, CE Mark |
| Chromatan | Tangential Chromatography | Single-use column-free proteins and vaccines purification. | Not Applicable |
| ALung | Hemolung® RAS | Respiratory Assist System | EU |
| Complexa | CXA-10 | Fibrosis, inflammation, and renal diseases | In Process |
| Forest Devices | AlphaStroke | Stroke screening | In Process |
| Rinovum Women’s Health | Stork™ Rinovum Vitamin Line | Reproductive Health Aid | FDA |
BioAdvance Biotechnology Greenhouse
of Southeastern Pennsylvania
215.966.6214 | bioadvance.com
Life Sciences Greenhouse
of Central Pennsylvania
717.635.2100 | lsgpa.com
Pittsburgh Life Sciences
Greenhouse
412.201.7370 | plsg.com
Recent Posts
READ MORE>>
Source LSGPA
READ MORE>>
Source Bio Advance
Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts – Cognition Therapeutics, Inc.
Congratulations to Cognition Therapeutics. This PLSG portfolio company was recently awarded a $3.3 million grant from the National Institute..
4 likes, 0 comments ⋅ 15 hours ago
(more…)